Human CYP1A1, diet and dioxin-induced hypertension
Human CYP1A1, diet and dioxin-induced hypertension
批准号:
8366871
负责人:
Mary K Walker
金额:
$45.3万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2015-08-31
关键词:
AdultAmerican Heart AssociationAnimal ModelAortaArachidonic AcidsAromatic HydrocarbonsArteriesBlood PressureBlood Pressure MonitorsBlood VesselsCYP1A1 geneCardiovascular DiseasesCardiovascular systemConsumptionContractsCyclooxygenase InhibitorsCytochromesDataDietDietary FactorsDioxinsDiseaseDrug Delivery SystemsEatingEnvironmental PollutantsEquilibriumExhibitsExposure toFatty AcidsFigs - dietaryFish OilsFishesFunctional disorderGene ExpressionGene ProteinsGenesGoalsHealthHepaticHumanHypertensionIndividualIntakeKnockout MiceLinkLipoxygenaseMediatingMesenteryMorbidity - disease rateMusOmega-3 Fatty AcidsOrthologous GeneOutcomePhysiologicalPolychlorinated BiphenylsProductionProstaglandin-Endoperoxide SynthaseProstaglandinsResearchResistanceTestingTetrachlorodibenzodioxinThromboxanesTimeVascular DiseasesVasoconstrictor AgentsWorkcardiovascular disorder riskcardiovascular risk factorcigarette smokingdibenzo(1,4)dioxindiphenyldisorder riskfeedingimprovedin vivomortalitynovelpollutantpreventprotein expressionreceptorresponserisk benefit ratiovasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Considerable evidence demonstrates that dietary omega-3 polyunsaturated fatty acids (?-3 PUFAs) protect against cardiovascular morbidity and mortality. Although the American Heart Association recommends that all individuals consume ?-3 PUFAs from fish or fish oil supplements, many individuals avoid fish consumption due to concern about accumulated environmental pollutants. It is well known that halogenated aromatic hydrocarbon (HAH) pollutants bioaccumulate in fish and studies have linked human HAH exposure to an increased risk of cardiovascular disease. Exposure to HAHs highly induces cytochrome P4501A1 (CYP1A1) and notably, ?-3 PUFAs are the preferred endogenous fatty acid substrates for CYP1A1. Thus, sustained CYP1A1 induction could decrease ?-3 PUFAs, contributing to cardiovascular disease risk resulting from HAH exposure. Our research shows that exposure to a prototypical HAH, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), induces vascular dysfunction and hypertension in mice and these effects require induction of CYP1A1. Our preliminary data show that TCDD exposure of mice for 2 wks (prior to an increase in blood pressure) highly induces CYP1A1 in resistance arteries and depletes hepatic ?-3 PUFAs. This exposure also induces vascular gene expression consistent with ?-3 PUFA depletion and production of endothelial-derived contracting factors in CYP1A1 wildtype (WT), but not knockout (KO) mice. Further, TCDD increases arachidonic acid (AA)-mediated vasoconstriction and an ?-3 PUFA-enriched diet normalizes this effect. We hypothesize that CYP1A1 mediates TCDD-induced vascular dysfunction and hypertension via ?-3 PUFA depletion. We further hypothesize that human CYP1A1 will be as effective as mouse CYP1A1 in mediating these responses in vivo. To test this, in Aim 1 we will establish the requirement for CYP1A1 in TCDD-induced changes in vascular fatty acids and gene/protein expression, using CYP1A1 WT and KO mice, as well as mice where the mouse CYP1A1 and 1A2 genes have been replaced with the human CYP1A1/1A2 orthologs (hCYP1A). We will investigate the time course and magnitude of changes and the ability of ?-3 PUFAs to prevent them. The humanized CYP1A mouse will significantly improve our ability to extrapolate from mice to humans. In Aim 2 we will determine the mechanism by which CYP1A1 mediates TCDD-induced vascular dysfunction, using CYP1A1 WT and hCYP1A mice, and studying the aorta and mesenteric vasoreactivity ? and ?-3 PUFAs. In Aim 3 we will determine the ability of human CYP1A1 to mediate TCDD-induced hypertension and dietary ?-3 PUFAs to prevent it, using radiotelemetry. If proven correct these studies would provide the first experimental evidence that benefits of ?-3 PUFAs can offset vascular disease risk posed by HAH pollutants accumulated in fish. These outcomes also have broader human health implications. In particular, cigarette smoke has high levels of HAHs that induce CYP1A1 potentially contributing to vascular disease. Thus, CY?P1A1 inhibition could be a novel drug target for reducing vascular disease risk as a consequence of sustained CYP1A1 induction.
PUBLIC HEALTH RELEVANCE: The American Heart Association recognizes that eating fish provides significant protection from developing cardiovascular disease and these benefits are derived from the intake of omega-3 polyunsaturated fatty acids; however, many individuals avoid fish consumption due to concern about accumulated environmental pollutants. While attempts have been made to estimate a risk-benefit ratio for fish consumption, no studies have experimentally investigated the interaction between dietary omega-3 polyunsaturated fatty acids, pollutants, and cardiovascular disease. The proposed studies will use an animal model to investigate the ability of dietary omega-3 polyunsaturated fatty acids to protect against pollutant
induced vascular disease and hypertension, testing the premise that benefits of fish-derived fatty acids offset cardiovascular risk from pollutants accumulated in fish.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Dietary Omega-3 Polyunsaturated Fatty Acids Prevent Vascular Dysfunction and Attenuate Cytochrome P4501A1 Expression by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin.
膳食 Omega-3 多不饱和脂肪酸可预防血管功能障碍并通过 2,3,7,8-四氯二苯并-P-二恶英减弱细胞色素 P4501A1 表达。
DOI:
10.1093/toxsci/kfw145
发表时间:
2016
期刊:
Toxicological sciences : an official journal of the Society of Toxicology
影响因子:
--
作者:
[Wiest,ElaniF, Walsh-Wilcox,MaryT, Rothe,Michael, Schunck,Wolf-Hagen, Walker,MaryK]
通讯作者:
Walker,MaryK
Cytochrome P4501A1 and Vascular Injury
-
批准号:8291248
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2011
-
负责人:Mary K Walker
-
依托单位:
Cytochrome P4501A1 and Vascular Injury
-
批准号:8203455
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2011
-
负责人:Mary K Walker
-
依托单位:
Ah Receptor and Endothelin-Dependent Hypertension
-
批准号:7820842
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2009
-
负责人:Mary K Walker
-
依托单位:
Ah Receptor and Endothelin-Dependent Hypertension
-
批准号:7788135
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2006
-
负责人:Mary K Walker
-
依托单位:
Ah Receptor and Endothelin-Dependent Hypertension
-
批准号:7105401
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2006
-
负责人:Mary K Walker
-
依托单位:
2006 Mechanisms in Toxicity Gordon Research Conference
-
批准号:7459024
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2006
-
负责人:Mary K Walker
-
依托单位:
Ah Receptor and Endothelin-Dependent Hypertension
-
批准号:7194301
-
项目类别:
-
资助金额:$36.16万
-
财政年份:2006
-
负责人:Mary K Walker
-
依托单位:
Ah Receptor and Endothelin-Dependent Hypertension
-
批准号:7576172
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2006
-
负责人:Mary K Walker
-
依托单位:
Ah Receptor and Endothelin-Dependent Hypertension
-
批准号:7367167
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2006
-
负责人:Mary K Walker
-
依托单位:
Fetal Dioxin Exposure and Adult Heart Disease
-
批准号:6792999
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2004
-
负责人:Mary K Walker
-
依托单位:
Fetal Dioxin Exposure and Adult Heart Disease
-
批准号:6888089
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2004
-
负责人:Mary K Walker
-
依托单位:
Fetal Dioxin Exposure and Adult Heart Disease
-
批准号:7048031
-
项目类别:
-
资助金额:$4.43万
-
财政年份:2004
-
负责人:Mary K Walker
-
依托单位:
Fetal Dioxin Exposure and Adult Heart Disease
-
批准号:7036520
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2004
-
负责人:Mary K Walker
-
依托单位:
EFFECTS OF DIOXIN ON CORONARY ANGIOGENESIS
-
批准号:6518142
-
项目类别:
-
资助金额:$17.46万
-
财政年份:2000
-
负责人:Mary K Walker
-
依托单位:
REGULATION OF NA,K ATPASE BY THE AH RECEPTOR
-
批准号:6637213
-
项目类别:
-
资助金额:$16.16万
-
财政年份:2000
-
负责人:Mary K Walker
-
依托单位:
EFFECTS OF DIOXIN ON CORONARY ANGIOGENESIS
-
批准号:6382290
-
项目类别:
-
资助金额:$16.95万
-
财政年份:2000
-
负责人:Mary K Walker
-
依托单位:
EFFECTS OF DIOXIN ON CORONARY ANGIOGENESIS
-
批准号:6050988
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2000
-
负责人:Mary K Walker
-
依托单位:
REGULATION OF NA,K ATPASE BY THE AH RECEPTOR
-
批准号:6525245
-
项目类别:
-
资助金额:$19.03万
-
财政年份:2000
-
负责人:Mary K Walker
-
依托单位:
REGULATION OF NA,K ATPASE BY THE AH RECEPTOR
-
批准号:6382360
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2000
-
负责人:Mary K Walker
-
依托单位:
REGULATION OF NA,K ATPASE BY THE AH RECEPTOR
-
批准号:6835498
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2000
-
负责人:Mary K Walker
-
依托单位:
海外基金